Transcription Inhibition of Heat Shock Proteins: A Strategy for Combination of 17-allylamino-17-demethoxygeldanamycin and Actinomycin D

por Cervantes-Gomez, Fabiola, Nimmanapalli, Ramadevi, Gandhi, Varsha
Publicado em 2009

ATP Analog Enhances the Actions of a Heat Shock Protein 90 Inhibitor in Multiple Myeloma Cells

por Cervantes-Gomez, Fabiola, Nimmanapalli, Ramadevi, Gandhi, Varsha
Publicado em 2011

Biological Effects of the Pim Kinase Inhibitor, SGI-1776, in Multiple Myeloma

por Cervantes-Gomez, Fabiola, Chen, Lisa S., Orlowski, Robert Z., Gandhi, Varsha
Publicado em 2013

Combination of Pim kinase inhibitors and Bcl-2 antagonists in chronic lymphocytic leukemia cells

por Cervantes-Gomez, Fabiola, Lavergne, Bethany, Keating, Michael J., Wierda, William G., Gandhi, Varsha
Publicado no Leuk Lymphoma (2015)

Proteasome inhibitor carfilzomib complements ibrutinib’s action in chronic lymphocytic leukemia

por Lamothe, Betty, Cervantes-Gomez, Fabiola, Sivina, Mariela, Wierda, William G., Keating, Michael J., Gandhi, Varsha
Publicado no Blood (2015)

PIM kinase inhibitor, AZD1208, inhibits protein translation and induces autophagy in primary chronic lymphocytic leukemia cells

por Cervantes-Gomez, Fabiola, Stellrecht, Christine M., Ayres, Mary L., Keating, Michael J., Wierda, William G., Gandhi, Varsha
Publicado no Oncotarget (2019)

Pharmacological and protein profiling suggest venetoclax (ABT-199) as optimal partner with ibrutinib in chronic lymphocytic leukemia

por Cervantes-Gomez, Fabiola, Lamothe, Betty, Woyach, Jennifer A., Wierda, William G., Keating, Michael J., Balakrishnan, Kumudha, Gandhi, Varsha
Publicado no Clin Cancer Res (2015)